Chargement en cours...
The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment
Asparaginase is an important drug in the treatment regimen for acute lymphoblastic leukemia. Asparaginase depletes circulating asparagine and glutamine, activating an amino acid stress response (AAR) involving phosphorylation of eukaryotic initiation factor 2 (eIF2) by general control nonderepressib...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Physiological Society
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3840205/ https://ncbi.nlm.nih.gov/pubmed/24002574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00080.2013 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|